Literature DB >> 24398297

Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers.

Lin Chen1, Sadagopan Magesh1, Hong Wang2, Chung S Yang3, Ah-Ng Tony Kong4, Longqin Hu5.   

Abstract

Novel iminothiazinylbutadienols and divinylpyrimidinethiones were designed and synthesized as analogues of curcumin with its diketone moiety masked as a heterocyclic adduct with thiourea. The chemical stability of these novel heterocyclic compounds was improved as compared to curcumin. They exhibit longer half-lives and do not react with nucleophilic thiols under physiological conditions. In an ARE-luciferase reporter assay, some of these new curcumin analogues are more effective ARE activators than curcumin and isothiocyanates.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ARE induction; Anti-inflammatory agents; Curcumin; Divinylpyrimidinethiones; Iminothiazinylbutadienols

Mesh:

Substances:

Year:  2013        PMID: 24398297      PMCID: PMC3936471          DOI: 10.1016/j.bmcl.2013.12.072

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  36 in total

1.  Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin.

Authors:  Thomas Philip Robinson; Tedman Ehlers; Richard B Hubbard IV; Xianhe Bai; Jack L Arbiser; David J Goldsmith; J Phillip Bowen
Journal:  Bioorg Med Chem Lett       Date:  2003-01-06       Impact factor: 2.823

2.  Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin.

Authors:  Babasaheb Yadav; Sebastien Taurin; Rhonda J Rosengren; Marc Schumacher; Marc Diederich; Tiffany J Somers-Edgar; Lesley Larsen
Journal:  Bioorg Med Chem       Date:  2010-08-01       Impact factor: 3.641

3.  Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.

Authors:  Hironori Ohtsu; Zhiyan Xiao; Junko Ishida; Masahiro Nagai; Hui-Kang Wang; Hideji Itokawa; Ching-Yuan Su; Charles Shih; Tzuying Chiang; Eugene Chang; YiFen Lee; Meng-Yin Tsai; Chawnshang Chang; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2002-11-07       Impact factor: 7.446

Review 4.  Anticancer potential of curcumin: preclinical and clinical studies.

Authors:  Bharat B Aggarwal; Anushree Kumar; Alok C Bharti
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

5.  Acetylacetone-cleaving enzyme Dke1: a novel C-C-bond-cleaving enzyme from Acinetobacter johnsonii.

Authors:  Grit D Straganz; Anton Glieder; Lothar Brecker; Douglas W Ribbons; Walter Steiner
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

Review 6.  Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents.

Authors:  Sadagopan Magesh; Yu Chen; Longqin Hu
Journal:  Med Res Rev       Date:  2012-05-01       Impact factor: 12.944

7.  Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer.

Authors:  Mathilde Bayet-Robert; Fabrice Kwiatkowski; Marianne Leheurteur; Françoise Gachon; Eloïse Planchat; Catherine Abrial; Marie-Ange Mouret-Reynier; Xavier Durando; Chantal Barthomeuf; Philippe Chollet
Journal:  Cancer Biol Ther       Date:  2010-01-21       Impact factor: 4.742

8.  Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element.

Authors:  Elisabeth Balogun; Martha Hoque; Pengfei Gong; Erin Killeen; Colin J Green; Roberta Foresti; Jawed Alam; Roberto Motterlini
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

9.  Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis.

Authors:  P V Leyon; G Kuttan
Journal:  J Exp Clin Cancer Res       Date:  2003-03

10.  Molecular mechanisms of anti-angiogenic effect of curcumin.

Authors:  Anupama E Gururaj; Madesh Belakavadi; Deepak A Venkatesh; Dieter Marmé; Bharathi P Salimath
Journal:  Biochem Biophys Res Commun       Date:  2002-10-04       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.